Your browser doesn't support javascript.
loading
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia.
McCall, David; Roth, Michael; Mahadeo, Kris M; Toepfer, Laurie; Nunez, Cesar; Short, Nicholas J; Daver, Naval; Kadia, Tapan M; DiNardo, Courtney; Yi, Joanna S; Cuglievan, Branko.
Afiliação
  • McCall D; Department of Pediatrics.
  • Roth M; Department of Pediatrics.
  • Mahadeo KM; Department of Pediatrics.
  • Toepfer L; Department of Pediatrics.
  • Nunez C; Department of Pediatrics.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Yi JS; Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX.
  • Cuglievan B; Department of Pediatrics.
Blood Adv ; 5(23): 5215-5219, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34592761

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2021 Tipo de documento: Article